Evidence map›Paper›PMID 28611958›Full record

ReviewHip & pelvis2017

Management of Blood Loss in Hip Arthroplasty: Korean Hip Society Current Consensus.

Joo-Hyoun Song, Jang Won Park, Young-Kyun Lee, In-Sung Kim, Jae-Hwi Nho, Kyung-Jae Lee, Kwan Kyu Park, Yeesuk Kim, Jai Hyung Park, Seung Beom Han

Open access · hybridAbstract readReview
In one paragraph

Review in Hip & pelvis, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed, 1 pooled it
0.9field-weighted citation impact, top 30% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 1 synthesis or guideline pooled it, 26 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Article
  4. Article
  5. Article
  6. Review
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Observational
  13. Review
  14. Article
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 10 institutions in 1 country.

Joo-Hyoun SongDepartment of Orthopaedics, St. Vincent's Hospital, The Catholic University of Korea, Suwon, Korea.
Jang Won ParkDepartment of Orthopaedic Surgery, School of Medicine, Ewha Womans University, Seoul, Korea.
Young-Kyun LeeDepartment of Orthopaedic Surgery, Seoul National University Bundang Hospital, Seongnam, Korea.
In-Sung KimDepartment of Orthopedic Surgery, Hallym University Dongtan Sacred Heart Hospital, Hwaseong, Korea.
Jae-Hwi NhoDepartment of Orthopaedic Surgery, Soonchunhyang University Hospital, Seoul, Korea.
Kyung-Jae LeeDepartment of Orthopaedic Surgery, Keimyung University School of Medicine, Daegu, Korea.
Kwan Kyu ParkDepartment of Orthopaedic surgery, Yonsei University, College of Medicine, Seoul, Korea.
Yeesuk KimDepartment of Orthopaedic Surgery, School of Medicine, Hanyang University, Seoul, Korea.
Jai Hyung ParkDepartment of Orthopaedic surgery, Kangbuk Samsung Hospital, Sungkyunkwan University School of Medicine, Seoul, Korea.
Seung Beom HanDepartment of Orthopedic Surgery, Korea University Anam Hospital, Seoul, Korea.
Ewha Womans University · KRHallym University Dongtan Sacred Heart Hospital · KRHanyang University · KRKeimyung University · KRKorea University Medical Center · KRSeoul National University Bundang Hospital · KRSoonchunhyang University Hospital Seoul · KRSungkyunkwan University · KRThe Catholic University of Korea St. Vincent's Hospital · KRYonsei University · KR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The volume of hip arthroplasty is stiffly increasing because of excellent clinical outcomes, however it has not been shown to decrease the incidence of transfusions due to bleeding related to this surgery. This is an important consideration since there are concerns about the side effects and social costs of transfusions. First, anemia should be assessed at least 30 days before elective hip arthroplasty, and if the subject is diagnosed as having anemia, an additional examination of the cause of the anemia should be carried and steps taken to address the anemia. Available iron treatments for anemia take 7 to 10 days to facilitate erythropoiesis, and preoperative iron supplementation, either oral or intravenous, is recommended. When using oral supplements for iron storage, administer elemental iron 100 mg daily for 2 to 6 weeks before surgery, and calculate the dose using intravenous supplement. Tranexamic acid (TXA) is a synthetic derivative of the lysine component, which reduces blood loss by inhibiting fibrinolysis and clot degradation. TXA is known to be an effective agent for reducing postoperative bleeding and reducing the need for transfusions in primary and revision total hip arthroplasties. Patient blood management has improved the clinical outcome after hip arthroplasty through the introduction and research of various agents, thereby reducing the need for allogeneic blood transfusions and reducing the risk of transfusion-related infections and the duration of hospitalizations.

Indexed as

Blood managementHip arthroplastyTransfusion

Identifiers

PMID28611958
PMCPMC5465399
OpenAlexW2622754140

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.